Macrogenics Inc SEC filings MGNX

Macrogenics Inc has 944 filings in SEC EDGAR's recent list, going back to Nov 12, 2003. Its latest annual report, Form 10-K, was filed on Mar 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Macrogenics Inc SEC filings
Form Description Filed Period
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 3, 2026 Oct 30, 2026
8-K Current report
Other events
Oct 23, 2026 Oct 23, 2026
S-8 Employee stock plan registration Sep 3, 2026 —
8-K/A Amended current report Sep 3, 2026 Sep 3, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Other events
Jul 23, 2026 Jul 23, 2026
8-K Current report
Officer or director change
Jul 8, 2026 Jul 1, 2026
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Jul 7, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
May 20, 2026 May 19, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Material agreement, Regulation FD disclosure
May 12, 2026 May 11, 2026
8-K Current report
Material agreement, Other events
May 4, 2026 May 1, 2026
DEFA14A Additional proxy material Apr 22, 2026 —
8-K Current report
Other events
Apr 8, 2026 Apr 8, 2026
DEFA14A Additional proxy material Apr 8, 2026 —
DEF 14A Proxy statement Apr 8, 2026 May 19, 2026
8-K Current report
Results of operations
Mar 9, 2026 Mar 9, 2026
10-K Annual report Mar 9, 2026 Dec 31, 2025
8-K Current report
Other events
Mar 2, 2026 Mar 2, 2026
8-K Current report
Other events
Feb 24, 2026 Feb 23, 2026
8-K Current report
Officer or director change
Nov 20, 2025 Nov 14, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
S-8 Employee stock plan registration Aug 14, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 13, 2025 Aug 13, 2025
8-K Current report
Material agreement, Other events
Jun 10, 2025 Jun 9, 2025
8-K Current report
Shareholder vote results
May 22, 2025 May 21, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
DEFA14A Additional proxy material Apr 11, 2025 —
DEF 14A Proxy statement Apr 11, 2025 May 21, 2025
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Feb 26, 2025 Feb 25, 2025
UPLOAD Letter from the SEC Jan 10, 2025 —
CORRESP Letter to the SEC Jan 3, 2025 —
UPLOAD Letter from the SEC Dec 3, 2024 —
8-K Current report
Officer or director change
Nov 21, 2024 Nov 18, 2024
8-K Current report
Results of operations
Nov 5, 2024 Nov 5, 2024
10-Q Quarterly report Nov 5, 2024 Sep 30, 2024
8-K Current report
Officer or director change, Other events
Oct 30, 2024 Oct 25, 2024
8-K Current report
Other events
Sep 16, 2024 Sep 16, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Other events
Jul 30, 2024 Jul 30, 2024
8-K Current report
Other events
Jul 30, 2024 Jul 24, 2024
8-K Current report
Shareholder vote results
May 23, 2024 May 21, 2024
S-8 Employee stock plan registration May 23, 2024 —
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
8-K Current report
Other events
May 9, 2024 May 9, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
ARS Annual report to shareholders Apr 8, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 8, 2024 —
DEF 14A Proxy statement Apr 8, 2024 May 21, 2024
8-K Current report
Other events
Apr 3, 2024 Apr 3, 2024
8-K Current report
Results of operations
Mar 7, 2024 Mar 7, 2024
10-K Annual report Mar 7, 2024 Dec 31, 2023
EFFECT Filing Nov 15, 2023 —
CORRESP Letter to the SEC Nov 14, 2023 —
UPLOAD Letter from the SEC Nov 10, 2023 —
S-3 Shelf registration Nov 6, 2023 —
8-K Current report
Results of operations
Nov 6, 2023 Nov 6, 2023
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Agreement ended
Sep 22, 2023 Sep 19, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
S-8 Employee stock plan registration Jun 6, 2023 —
8-K Current report
Shareholder vote results
Jun 2, 2023 May 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
EFFECT Filing Apr 27, 2023 —
DEFA14A Additional proxy material Apr 19, 2023 —
ARS Annual report to shareholders Apr 17, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 17, 2023 —
DEF 14A Proxy statement Apr 17, 2023 May 31, 2023
8-K Current report
Other events
Mar 24, 2023 Mar 22, 2023
POS AM Filing Mar 15, 2023 —
S-8 Employee stock plan registration Mar 15, 2023 —
10-K Annual report Mar 15, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 15, 2023 Mar 15, 2023
POSASR Filing Mar 15, 2023 —
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
8-K Current report
Material agreement, Other events
Mar 9, 2023 Mar 8, 2023
8-K Current report
Other events
Feb 14, 2023 Feb 13, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 5, 2023 Jan 3, 2023
8-K Current report
Officer or director change
Dec 21, 2022 Dec 19, 2022
8-K Current report
Material agreement
Dec 16, 2022 Dec 14, 2022
8-K Current report
Other events
Nov 18, 2022 Nov 17, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Material agreement, Regulation FD disclosure
Oct 17, 2022 Oct 17, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
8-K Current report
Other events
Jul 8, 2022 Jul 8, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
May 24, 2022 May 22, 2022
8-K Current report
Shareholder vote results
May 23, 2022 May 19, 2022
10-Q Quarterly report May 3, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 3, 2022 May 3, 2022
DEFA14A Additional proxy material Apr 8, 2022 —
DEF 14A Proxy statement Apr 8, 2022 May 19, 2022
S-8 Employee stock plan registration Feb 24, 2022 —
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Officer or director change
Jan 7, 2022 Jan 5, 2022
10-Q Quarterly report Nov 2, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 2, 2021 Nov 2, 2021
8-K Current report
Officer or director change
Sep 27, 2021 Sep 23, 2021
8-K Current report
Other events
Sep 16, 2021 Sep 16, 2021
8-K Current report
Other events
Sep 8, 2021 Sep 7, 2021
8-K Current report
Results of operations
Jul 29, 2021 Jul 29, 2021
10-Q Quarterly report Jul 29, 2021 Jun 30, 2021
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 16, 2021 Jun 15, 2021
8-K Current report
Shareholder vote results
May 18, 2021 May 13, 2021
8-K Current report
Other events
Apr 29, 2021 Apr 29, 2021
424B5 Prospectus supplement Apr 29, 2021 —
8-K Current report
Results of operations
Apr 29, 2021 Apr 29, 2021
10-Q Quarterly report Apr 29, 2021 Mar 31, 2021
8-K Current report
Bylaw or fiscal year change
Apr 2, 2021 Mar 30, 2021
DEFA14A Additional proxy material Apr 2, 2021 —
DEF 14A Proxy statement Apr 2, 2021 May 13, 2021
S-8 Employee stock plan registration Feb 25, 2021 —
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Officer or director change
Feb 11, 2021 Feb 10, 2021
8-K Current report
Other events
Dec 16, 2020 Dec 16, 2020
8-K Current report
Material agreement
Nov 30, 2020 Nov 25, 2020
S-3ASR Automatic shelf registration Nov 4, 2020 —
10-Q Quarterly report Nov 4, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 4, 2020 Nov 4, 2020
8-K Current report
Material agreement
Oct 16, 2020 Oct 13, 2020
8-K Current report
Results of operations
Jul 31, 2020 Jul 30, 2020
10-Q Quarterly report Jul 31, 2020 Jun 30, 2020
8-K Current report
Other events
Jun 19, 2020 Jun 19, 2020
424B5 Prospectus supplement Jun 19, 2020 —
8-K Current report
Other events
Jun 18, 2020 Jun 16, 2020
8-K Current report
Other events
May 29, 2020 May 29, 2020
8-K Current report
Shareholder vote results
May 14, 2020 May 14, 2020
8-K Current report
Other events
May 13, 2020 May 13, 2020
8-K Current report
Results of operations
May 5, 2020 May 5, 2020
10-Q Quarterly report May 5, 2020 Mar 31, 2020
DEFA14A Additional proxy material Apr 28, 2020 —
8-K Current report
Other events
Apr 28, 2020 Apr 28, 2020
DEFA14A Additional proxy material Apr 3, 2020 —
DEF 14A Proxy statement Apr 3, 2020 May 14, 2020
PRE 14A Preliminary proxy statement Mar 23, 2020 May 14, 2020
S-8 Employee stock plan registration Mar 12, 2020 —
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 4, 2020 Feb 27, 2020
10-K/A Amended annual report Mar 2, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 25, 2020 Feb 25, 2020
10-K Annual report Feb 25, 2020 Dec 31, 2019
8-K Current report
Officer or director change
Feb 5, 2020 Jan 30, 2020
8-K Current report
Results of operations, Other events
Jan 10, 2020 Jan 9, 2020
EFFECT Filing Jan 3, 2020 —
424B5 Prospectus supplement Jan 3, 2020 —
CORRESP Letter to the SEC Dec 31, 2019 —
UPLOAD Letter from the SEC Dec 31, 2019 —
S-3 Shelf registration Dec 23, 2019 —
UPLOAD Letter from the SEC Dec 23, 2019 —
CORRESP Letter to the SEC Dec 11, 2019 —
UPLOAD Letter from the SEC Dec 6, 2019 —
8-K Current report
Results of operations
Nov 6, 2019 Nov 6, 2019
10-Q Quarterly report Nov 6, 2019 Sep 30, 2019
8-K Current report
Other events
Oct 22, 2019 Oct 22, 2019
CT ORDER Filing Aug 6, 2019 —
10-Q Quarterly report Jul 31, 2019 Jun 30, 2019
8-K Current report
Results of operations
Jul 31, 2019 Jul 31, 2019
8-K Current report
Agreement ended
Jul 17, 2019 Jul 17, 2019
8-K Current report
Shareholder vote results
May 21, 2019 May 16, 2019
8-K Current report
Results of operations
May 1, 2019 Mar 31, 2019
10-Q Quarterly report May 1, 2019 Mar 31, 2019
DEF 14A Proxy statement Apr 5, 2019 May 16, 2019
CT ORDER Filing Mar 19, 2019 —
S-8 Employee stock plan registration Mar 14, 2019 —
10-K Annual report Feb 26, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 26, 2019 Feb 26, 2019
8-K Current report
Other events
Feb 15, 2019 Feb 12, 2019
424B5 Prospectus supplement Feb 13, 2019 —
424B5 Prospectus supplement Feb 12, 2019 —
8-K Current report
Other events
Feb 6, 2019 Feb 6, 2019
8-K Current report
Other events
Jan 25, 2019 Jan 25, 2019
8-K Current report
Other events
Dec 7, 2018 Dec 7, 2018
8-K Current report
Results of operations
Nov 7, 2018 Nov 7, 2018
10-Q Quarterly report Nov 7, 2018 Sep 30, 2018
8-K Current report
Results of operations
Aug 7, 2018 Aug 7, 2018
10-Q Quarterly report Aug 7, 2018 Jun 30, 2018
8-K Current report
Shareholder vote results
May 23, 2018 May 17, 2018
CT ORDER Filing May 14, 2018 —
8-K Current report
Results of operations
May 7, 2018 May 7, 2018
10-Q Quarterly report May 7, 2018 Mar 31, 2018
DEF 14A Proxy statement Apr 6, 2018 May 17, 2018
8-K Current report
Other events
Apr 2, 2018 Mar 27, 2018
424B5 Prospectus supplement Mar 28, 2018 —
424B5 Prospectus supplement Mar 26, 2018 —
S-8 Employee stock plan registration Mar 15, 2018 —
CT ORDER Filing Mar 12, 2018 —
8-K Current report
Officer or director change
Feb 27, 2018 Feb 27, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MGNX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Rockville, MD
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1125345

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.